Cited by 117Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular HealthChronic Disease Management Strategies

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Open access

Zhao, Yimin, Zhuang, Zhenhuang, Li, Yueying, Xiao, Wendi, Song, Zimin, Huang, Ninghao, Wang, Wenxiu, Dong, Xue, Jia, Jinzhu, Clarke, Robert, Huang, Tao·2024·Nature Communications

DOI 10.1038/s41467-024-46686-xPMC PMC10951224

Open this paper in CoChat — free account Open PDF

Abstract

The connection between triglyceride-rich lipoproteins and cardiometabolic multimorbidity, characterized by the concurrence of at least two of type 2 diabetes, ischemic heart disease, and stroke, has not been definitively established. We aim to examine the prospective associations between serum remnant cholesterol, triglycerides, and the risks of progression from first cardiometabolic disease to multimorbidity via multistate modeling in the UK Biobank. We also evaluate the causality of these associations via Mendelian randomization using 13 biologically relevant SNPs as the genetic instruments. Here we show that elevated remnant cholesterol and triglycerides are significantly associated with gradually higher risks of cardiometabolic multimorbidity, particularly the progression of ischemic heart disease to the multimorbidity of ischemic heart disease and type 2 diabetes. These results advocate for effective management of remnant cholesterol and triglycerides as a potential strategy in mitigating the risks of cardiometabolic multimorbidity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41467-024-46686-x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Genetic associations between remnant cholesterol, triglycerides, and cardiometabolic multimorbidity via one-sample Mendelian randomization among the UK Biobank participants (n = 376,712 for remnant cholesterol and n = 411,930 for triglycerides). Causal odds ratios were calculated adjusting for age and sex. Data are presented as odd ratios with 95% confidence intervals. The dot refers to the odd ratio while the solid line refers to the 95% confidence interval. The dash line refers to odd ratio value of one as the reference. Abbreviations: CI confidence interval, IHD ischemic heart disease, OR odds ratio, T2D type 2 diabetes. Statistical significance is set at two-sided P value < 0.05.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Association of cardiometabolic multimorbidity with mortality
Di Angelantonio, E., Kaptoge, S., Wormser, D., Willeit, P., Butterworth, A. S., Bansal, N., O’Keeffe, L. M., Gao, P., Wood, A. M., Burgess, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.7008 · Cited by 1,155
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine
Elliott, P., Peakman, T. C., & Biobank, O. B. O. U. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym276 · Cited by 1,004
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Global epidemiology of dyslipidaemias
Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D., & Catapano, A. L. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00541-4 · Cited by 882

Show all 53 references

Sorted by citations

Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018
Lai, H., Tu, Y., Liao, C., Zhang, S., He, L., & Li, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02667-y · Cited by 70
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
Cummings, B. B., Joing, M. P., Bouchard, P. R., Milton, M. N., Moesta, P. F., Ramanan, V., Lane, A., Hirman, J., Trauger, J. W., Maratos-Flier, E., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00825-6 · Cited by 49
Transport functions of intestinal lymphatic vessels
Tso, P., Bernier‐Latmani, J., Petrova, T. V., & Liu, M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00996-z · Cited by 33
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Strandberg, T. E., Kovanen, P. T., Lloyd‐Jones, D. M., Raal, F. J., Santos, R. D., & Watts, G. F. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02089-0 · Cited by 29
[Incisional hernia after surgery for abdominal aortic aneurysm].
Augestad, K. M., Wilsgaard, T., & Solberg, S. K. (2002) · PubMed · Cited by 29
Interactions between lipid droplets and mitochondria in metabolic diseases
Wang, G., Sun, B., Liu, H., Hu, M., Xu, H., Li, H., Wang, X., & Tong, M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02759-4 · Cited by 34
The Cardioprotective Effects of Polyunsaturated Fatty Acids Depends on the Balance Between Their Anti- and Pro-Oxidative Properties
Sidorkiewicz, M. (2024) · Nutrients · doi:10.3390/nu16223937 · Cited by 30
Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation
Li, D., Lin, J., Yang, H., Zhou, L., Li, Y., Xu, Z., Sun, L. N., Zhang, X., Xu, W., & Wang, Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02790-w · Cited by 35
Self-citation
Dietary medium-chain triacylglycerols in metabolic regulation
Cao, Y., Kanta, J. M., Bishop, C. A., Kiens, B., Fritzen, A. M., & Kleinert, M. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.09.010 · Cited by 25
Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a)
Wulff, A. B., & Nordestgaard, B. G. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf274 · Cited by 22
Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes
Elías-López, D., Wadström, B. N., Vedel‐Krogh, S., Kobylecki, C. J., & Nordestgaard, B. G. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01555-1 · Cited by 18
Aging and Sex Modify the Risk of Carotid Plaque Thrombosis Related to Dyslipidemic Profile
Servadei, F., Scimeca, M., Palumbo, V., Oddi, F. M., Bonfiglio, R., Giacobbi, E., Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., et al. (2025) · Stroke · doi:10.1161/strokeaha.125.051754 · Cited by 18
Life’s essential 8 and progression of cardiometabolic multimorbidity trajectory: a prospective study of UK biobank
Huang, M., Fu, R., Zhao, X., Liu, T., Li, X., & Jiang, W. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf247 · Cited by 15
Association between cardiorenal syndrome and depressive symptoms among the US population: a mediation analysis via lipid indices
Yu, G., Liu, L., Ma, Q., & He, H. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02356-x · Cited by 11
Association between physical activity-related metabolic signature and cardiometabolic diseases and multimorbidity: A cohort study from UK biobank
Wang, J., Zheng, Y., Jiang, Y., Suo, C., Zhang, T., Chen, X., & Xu, K. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108211 · Cited by 10
Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease
Borén, J., Packard, C. J., Nordestgaard, B. G., & Catapano, A. L. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf214 · Cited by 12
Biomarkers of multimorbidity: A systematic review
Zazzara, M. B., Triolo, F., Biscetti, L., Paparazzo, E., Fiorillo, M., Vetrano, D. L., & Onder, G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102870 · Cited by 16
Association between the cumulative atherogenic index of plasma and cardiometabolic multimorbidity: the mediating effects of the TyG index and body mass index
He, Q., Yu, W., Rao, X., Lin, D., You, Y., Yan, L., Liang, W., Hua, F., Guan, X., & Wang, X. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02875-9 · Cited by 9
Remnant cholesterol elevates hyperuricemia risk in the middle aged and elderly Chinese: a longitudinal study
Ma, J., Xu, F., & Zhang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-75951-8 · Cited by 8
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cognitive impairment in patients with acute mild ischemic stroke
Wang, H., Wang, J., Feng, D., Wang, L., & Zhang, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02693-2 · Cited by 8
Remnant cholesterol and body mass index jointly associate with cardiometabolic Multimorbidity with mediation analysis in CHARLS a prospective cohort study
Li, J., Fan, M., Yang, M., Huang, W., Shi, W., Zhang, D., Zhu, W., Liu, C., Xu, N., Zhang, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25958-6 · Cited by 8
Association between the CHG index and cardiometabolic multimorbidity: a nationwide prospective cohort and multi-community cross-sectional study
Liu, L., Meng, Y., Hu, L., Runa, A., Zhang, Y., & Gao, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1725495 · Cited by 8
Investigating the impact of extreme weather events and related indicators on cardiometabolic multimorbidity
Wu, D., Shi, Y., Wang, C., Li, C., Lu, Y., Wang, C., Zhu, W., Sun, T., Han, J., Zheng, Y., et al. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01361-x · Cited by 7
Two‐Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study
Wang, D., Zhang, Z., Zhang, Y., Chen, S., Qu, N., Li, H., Sun, Y., Tian, X., Han, X., Wu, S., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038559 · Cited by 8
Cumulative average remnant cholesterol inflammatory index and risk of cardiometabolic multimorbidity: evidence from a prospective nationwide cohort study in China
Zhang, W., Jing, C., Liu, X., & Hou, H. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-025-02850-w · Cited by 7
The association between triglyceride glucose-frailty index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study
Hou, X., Wang, G., & Gao, Y. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03191-3 · Cited by 7
Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology
Miyake, T., Furukawa, S., Matsuura, B., Yoshida, O., Kanamoto, A., Miyazaki, M., Shiomi, A., Nakaguchi, H., Okazaki, Y., Nakamura, Y., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae597 · Cited by 7
Association of C-reactive protein-triglycerides-glucose index-waist to height ratio and cardiometabolic multimorbidity in middle-aged and older adults: a nationwide cohort study
Du, J., Man, Z., Bai, X., Luo, D., Guo, Q., Wang, Y., Yan, Y., Su, X., & Zheng, W. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03151-x · Cited by 6
The prognostic role of remnant cholesterol in Asian menopausal women received percutaneous coronary intervention with acute coronary syndrome
Feng, X., Liu, Y., Yang, J., Zhou, Z., Yang, S., Zhou, Y., & Guo, Q. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02258-y · Cited by 6
The causal effects of remnant cholesterol on increased risk of cardiovascular diseases in East Asians
Lin, C., Wen, H., Yu, M., Huang, Q., Wang, Q., Lin, J., Yang, W., Wong, J. M. J., Xia, M., Tang, H., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04329-y · Cited by 5
The correlation between different metabolic scores and the risk of cardiometabolic comorbidities in hypertensive patients
Muheiyati, G., Wang, J., Chen, X., Guan, X., An, H., & Tao, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-01963-7 · Cited by 5
A cross-sectional analysis of remnant cholesterol-diabetes association in US adults
Li, X., Cui, G., & Xuemin, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-10961-8 · Cited by 5
Exercise-imitating adipocyte targeted poly-Lipidic DendroRNAi Nanovesicles for gene silencing-guided treatment of obesity in high-fat diet mouse model
Vasdev, N., Gupta, T., Bain, A., Mishra, M., Sahu, R., Pawar, B., & Tekade, R. K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146217 · Cited by 5
Shared genetic architecture between stroke and blood lipids: a large-scale genome-wide cross-trait analysis
Bai, W., Zhou, G., Jiang, H., Li, X., & Shao, J. (2025) · Human Genomics · doi:10.1186/s40246-025-00789-8 · Cited by 4
Diagnostic efficacy of remnant cholesterol inflammatory index in diabetic kidney disease: machine learning approaches
Xie, X., Li, X., Li, H., Gao, Y., Zhao, F., & Chen, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1642358 · Cited by 4
Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
Roh, E., Heo, J. H., Jung, H. N., Han, K., Kang, J. G., Lee, S. J., & Ihm, S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0406 · Cited by 4
Association of Cumulative Exposure to Triglyceride and Remnant Cholesterol With the Risk of Cardiovascular Disease in Hypertensive Patients With Target LDL‐C
Guo, S., Wang, C., Hu, T., Lan, L., Ge, Z., Huang, J., Chen, S., Wu, S., & Xue, H. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70084 · Cited by 4
Effect of plasma homocysteine on cardiometabolic multimorbidity among Chinese adults: a population-based and real-world evidence study
Li, L., Wang, J., Li, J., Li, M., Wang, J., Long, T., Zhengliu, Y., Tan, X., Peng, Y., & Hong, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1522212 · Cited by 5
Analysis of Metabolic Risk Factors for Microcirculation Disorders Post-Percutaneous Coronary Intervention and Predictive Model Construction: A Study on Patients with Unstable Angina
Li, K., Liu, S., Wang, J., Liu, Z., & Qi, C. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25739 · Cited by 4
Remnant cholesterol in early pregnancy as a predictor of gestational diabetes mellitus beyond triglyceride levels: a retrospective cohort study
Li, X.-X., Zhang, J.-Y., Chen, S.-Y., Wu, X., Ma, C., & Shen, H. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07871-y · Cited by 3
Spirometric patterns associated with the progression of cardiometabolic diseases in middle-aged and older adults: A prospective cohort study
Wang, N., Shi, X., Wang, T., Jia, X., Fan, Z., Yang, C., Wang, Y., Fan, J., Zhao, C., Niu, Y., et al. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108689 · Cited by 3
Redefining the association of triglycerides with all-cause and Cardiovascular Disease Mortality in the Chinese population: a nationwide, population-based, prospective cohort study of 3.8 million Chinese adults
Li, G., He, L., Bai, X., Chen, S., Dai, H., He, G., Yang, Y., Zhang, X., Cui, J., Li, X., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101689 · Cited by 4
Metabolic dysfunction associated steatotic liver disease, cardiometabolic multimorbidity and mortality: evidence from the UK biobank
Shen, C., Yang, R., Zhou, Y., Cheng, Y., Cheng, Y., Yao, Y., Lv, Y., Zeng, R., Zhao, Q., Jia, Y., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02845-2 · Cited by 3
Accelerometer-Derived Physical Activity Associated With Incidence and Progression Trajectory of Cardiometabolic Multimorbidity
Shen, F., Liu, H.-Y., Liu, Y., Yang, J., Zhang, L.-W., Li, Q.-M., Liu, L., Gong, T.-T., Wu, Q., & Gao, S. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.11.020 · Cited by 3
Associations of TyG-Derived Indices with Cardiometabolic Multimorbidity Risk in Community-Dwelling Older Adults: A Longitudinal Analysis Based on the GOLD-Health Cohort
Liao, C., Liu, H. T., Xu, S., Ling, Z., Zhuo, Y., Huang, G., Lin, W., & Zhang, Z. (2026) · Nutrients · doi:10.3390/nu18060985 · Cited by 3
Longitudinal cohort study on the dynamic changes of atherogenic index of plasma and the risk of cardiometabolic multimorbidity in middle - aged and elderly people
Hu, L., & Zhao, Z. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05387-z · Cited by 3
Associations of cumulative exposure and dynamic trajectories of the combined atherogenic and frailty index with incident cardiometabolic multimorbidity: a longitudinal analysis based on the China Health and Retirement Longitudinal Study (CHARLS)
Feng, X., Bi, D., Pan, Y., Liu, K., Lei, W., Tang, X., & Xia, J. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03235-8 · Cited by 3
Elevated remnant cholesterol predicts poor outcome in patients with premature acute coronary syndrome: a retrospective, single-center study
Zhang, M., Chen, J., Xia, W. T., Yu, Z., Zhang, C., Wang, W., Shao, Y., & Wang, B. (2025) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-025-03147-6 · Cited by 3
Self-citation
Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on Bifidobacterium concerning liver status
Chero‐Sandoval, L., Higuera‐Gómez, A., Martínez‐Urbistondo, M., Castejón, R., Mellor‐Pita, S., Moreno‐Torres, V., de Luis, D. A., Cuevas‐Sierra, A., & Martínez, J. A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14339 · Cited by 3
Obesity-depression-metabolism triad: amplification of cardiometabolic multimorbidity risk in Chinese adults (CHARLS 2011–2018)
He, Q., Wen, Y., Long, C., Lin, D., Lu, F., Zhong, M., Lin, W., Huang, S., Hua, S., Hua, F., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02724-1 · Cited by 3
The relationship between remnant cholesterol and young-onset myocardial infarction in patients with type 2 diabetes: a retrospective study
Gao, Y., Lei, T., Dang, P., & Li, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1512662 · Cited by 2
Self-citation
Impact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement
Sampath-Kumar, R., Padilla, E., Wilkinson, M. J., Barba, D. T., Aramburo, N., Mahmud, E., Ben‐Yehuda, O., & Taub, P. R. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102247 · Cited by 2
The role of instrumental activity of daily living disability in the association between circadian syndrome and cardiometabolic multimorbidity in Chinese middle-aged and older adults
Fang, Y., Wu, D., Shi, Z., Shen, J., Liu, E., Wu, X., Hu, W., & Lv, L. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01118-4 · Cited by 3
Life’s Essential 8 and healthy longevity among people with and without cardiometabolic multimorbidity: A prospective study of UK Biobank
Huang, M., Fu, R., Zhao, X., Liu, T., Li, X., & Jiang, W. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101433 · Cited by 2
Remnant cholesterol inflammatory index and mortality in cardiovascular-kidney-metabolic syndrome: a national study
Wang, L., Li, H., Wang, L., Hao, J., Zhang, Q., Zhou, Q., Wang, J., & Qi, C. (2026) · Archives of Medical Science · doi:10.5114/aoms/218809 · Cited by 2
Consensus Interdisciplinary Positions of the Metabolic Syndrome Supervisory Committee
Shlyakhto, E. V., Arutyunov, G. P., Babenko, A. Y., Boytsov, S. A., Вадимовна, В. С., Dedov, I. I., Drapkina, O. M., Олеговна, Е. С., Звартау, Н. Э., Ivashkin, V. T., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-7130 · Cited by 3
Enhancing decision support for type 2 diabetes mellitus comorbidity risk prediction: An end-to-end multi-task learning model
Yue, J., Luo, L., Guo, M., & Xu, C. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.128816 · Cited by 3
Triglyceride levels and remnant cholesterol triglyceride-rich lipoproteins in metabolic syndrome and diabetes
Симонова, Г. И., Щербакова, Л. В., Malyutina, S. K., Каширина, А. П., & Ragino, Y. I. (2024) · Ateroscleroz · doi:10.52727/2078-256x-2024-20-3-326-344 · Cited by 1
Effects of remnant cholesterol on adverse renal outcomes in lupus nephritis
Shi, X., Zhang, X., Lu, Y., Xiang, W., Wang, X., Yu, J., Ye, H., Wu, H., Tang, R., Xia, X., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02503-y · Cited by 1
Association between Remnant Cholesterol and Metabolic Syndrome beyond Conventional Lipid Parameters in Middle Age and Elderly Population: Bushehr Elderly Health (BEH) cohort
Esmaeili, S., Fahimfar, N., Esmaeili, B., Rezaei–Tavirani, M., Razi, F., & Bandarian, F. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01692-8 · Cited by 1
Impact of anti-osteoporotic treatments on hyperlipidemia risk in osteoporosis patients: evidence from a population-based retrospective cohort study
Hsieh, H., Tien, N., Lin, C., Wong, W.-H., Lee, W.-Y., Chen, C., Tsai, F., You, B., Fang, Y., & Lim, Y.-P. (2025) · European journal of medical research · doi:10.1186/s40001-025-03130-0 · Cited by 1
Purified Anthocyanins Indicated No Significant Effect on Arterial Stiffness, Four-Limb Blood Pressures and Cardiovascular Risk—A 12-Week Dose–Response Trial in Chinese Middle-Aged and Elderly Adults with Hyperglycemia
Liu, Z., Li, M., Chen, Y., Wang, C., Chen, J., Long, H., Liu, R., Chiou, J. A., & Chen, C. (2025) · Nutrients · doi:10.3390/nu18010112 · Cited by 1
Data-driven glycolipid network phenotypes reveal a graded risk spectrum for cardiometabolic multimorbidity: a prospective study in middle-aged and older Chinese adults
Lu, Z., Dong, B.-Q., Chen, L., Wei, H., & Zhang, H. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02894-6 · Cited by 1
Association between remnant cholesterol and stroke among patients with atrial fibrillation: A population-based cohort study
Li, Y., Ling, Y., Wu, H., Luo, S., Luo, J., Tang, X. W., Li, S., Zhuang, X., Wu, B., Xiong, Z., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.02.020 · Cited by 1
Self-citation
Causal statistical association between remnant cholesterol and coronary heart disease: genetic insights into the PSRC1–CELSR2–SORT1 gene cluster
Han, G., Lei, C. L., Shi, Y., Gao, J., Liu, X., Peng, K., Cai, Y., Hoi, P. M., & Yichong, L. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101047 · Cited by 1
Cholesterol metabolism dysregulated by key HBV mutations revealed through multi-omics profiling
Chen, Y., Lin, P., Jin, J., Deng, M., & Wei, D. (2026) · iScience · doi:10.1016/j.isci.2026.115844 · Cited by 1
Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits
Lee, M. P., Baca, P., Rivas, F., Zhang, A., Alegre-Díaz, J., Berumen-Campos, J., Kuri-Morales, P., North, K. E., Rodriguez, C. J., Stürmer, T., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101716 · Cited by 1
Association of pyridoxal 5′-phosphate (PLP) with lipid profiles: a population-based cohort study
Zhang, R., Chen, Y., Yan, X.-Q., Zhang, Y., Zhou, H. K., & Feng, Q. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1545301 · Cited by 1
Apolipoprotein A1 and Lipoprotein(a) as Biomarkers for the “Penumbra Freezing” in Acute Ischemic Stroke: Insights From a Case-Control and Mendelian Randomization Study
Liu, J., Xu, Z., Wen, Y., Guo, X., Chen, X., Liu, D., Li, L., & Liu, H. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673374444250901100551 · Cited by 1
Targeting triglycerides for cardiovascular risk reduction
Maiorca, C., Tramontano, D., Di Costanzo, A., & D’Erasmo, L. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04383-1
Remnant Cholesterol as a Predictor of Cardiovascular Outcomes in Acute Coronary Syndrome Patients with Low-Density Lipoprotein Cholesterol Levels Below 1.8 mmol/L: Insights from the MPCS-ACS StudyPreprint
Yang, H.-T., Yang, Y., Liu, J., Zhang, J., & Zhang, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4856821/v1
Impact of Smoking and Physical Activity on Total Cholesterol Levels, Lipoproteins, and Coronary Heart Disease Risk :Statistical Evidence.
Babiker, M. A., & Elsayir, H. A. (2024) · Nanotechnology Perceptions · doi:10.62441/nano-ntp.vi.3670
Non-linear relationship between the atherogenic index of plasma and ischemic stroke in the diabetic population in ICU: A multicenter retrospective cohort studyPreprint
Wu, L., Su, Z., Chen, X., Hu, H., & Wan, Q. (2024) · Research Square · doi:10.21203/rs.3.rs-5638991/v1
Demystifying the nuances of the lipid patient: a guide for primary care providers
Myerson, M. L., Gillett, K., O’Hara, J., Potter, R., & SKOLNIK, N. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101070
Elevated remnant cholesterol impairs sleep characteristics in individuals with newly diagnosed moderate-to-severe obstructive sleep apnea: a cross-sectional case–control study
Liu, Y., Zhang, F., Zhang, P., & Chen, L. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1648807
Postprandial metabolism of a reduced-fat meat product with added silicon from diatomaceous earth. A pilot randomized controlled four-way assay in humans
Vaquero, M. P., Álvarez, M. D., Zapatera, B., Saiz, A., & Cofrades, S. (2025) · Food & Function · doi:10.1039/d5fo00973a
Non-Traditional Lipid Ratios Predict Cardiovascular-Kidney-Metabolic Syndrome: Insights from Machine Learning Model Using NHANES DataPreprint
Wang, N., Zhang, J., Wang, Y., Zhang, X., Shi, Y., Zhang, L., Xing, Y., & Lv, Q. (2025) · medRxiv · doi:10.1101/2025.09.26.25336774
Multimorbidity quantification from the perspective of precision management: challenges and strategies
Huang, X., Guo, X., Gan, Y., Xu, A., Sun, K., Shen, H., Niu, Z., Zhang, Y., Guo, Y., Ma, Y., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2569988
Association of cumulative inflammation index with order of onset and long-term risk of cardiometabolic multimorbidity and depressive Symptoms: A prospective cohort study
Jiang, M., Li, X., & Lu, Y. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106157
Liquid/liquid interfacial plasmonic array for ultrasensitive cholesterol monitoring in complex dairy matrices
Du, S., & Liu, Z. (2025) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2025.108582
Beyond cardiovascular disease: remnant cholesterol as a novel risk factor for osteoarthritis
Xie, R., Chen, Z., Zhang, G., & Zhao, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1692833
Long-term body mass index variability and the risk of cardiometabolic multimorbidity in middle-aged and older adults: Insights from two prospective cohorts
Ren, X., Yang, M., Tian, J., Chang, X., Wang, G., & Liu, J. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200548 · Cited by 1
Association between multimorbidity and young-onset dementia: a prospective study
Chen, D., Zhang, M., Wen, Y., Han, H., Qin, Y., Zhang, R., Cao, H., & Yu, H. (2025) · BMC Public Health · doi:10.1186/s12889-025-25633-5
Association of triglyceride and cholesterol with vestibular vertigo: Evidence from univariable and multivariable mendelian randomization and mediation analysis
Mu, Y., Lu, Y., & Fu, W. (2026) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2025.101747
Association between remnant cholesterol and cardiac conduction block: A prospective cohort study
Li, X., Li, M., Cao, L., Shi, S., Zheng, N., Peng, S., Guan, B., Jiang, T., Liu, S., Tse, G., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.01.019
Association between remnant cholesterol and cardiometabolic multimorbidity in non-alcoholic fatty liver disease patients: evidence from a cross-sectional study
Xie, Y., Li, H., Xu, Y., Lv, D., Chu, J., Ye, J., & Huang, K. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04623-w
Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease
Wulff, A. B., Varbo, A., Nordestgaard, A. G., & Nordestgaard, B. G. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2639678 · Cited by 2
Association of pre-adolescent adverse childhood experiences with adolescent cholesterol levels: findings from the A-CHILD longitudinal study
Owusu, F. M., Nawa, N., Khin, Y. P., Nishimura, H., Doi, S. K., Isumi, A., & Fujiwara, T. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1745206
Remnant Cholesterol and Incident Depression in Aging: A 14-Year Prospective Cohort Study and Mendelian Randomization Analysis
Qi, M., Wang, M., Li, Y., & Cai, X. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117170
Self-citation
A competitive fluorescence sensor based on AuNPs-β-CD and 1-(4-(1,2,2-triphenylvinyl) phenyl)pyrene for cholesterol detection
Liu, S. M., Zhang, Y., Zhao, H., Liu, J., & Hou, C. (2026) · Microchimica Acta · doi:10.1007/s00604-026-08055-x
Associations between lipid parameters and incident cardio-renal-metabolic multimorbidity: The Tehran Lipid and Glucose Study
Masrouri, S., Ebrahimi, N., Molavizadeh, D., Esmaeili, F., Azizi, F., & Hadaegh, F. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104805
Cumulative exposure and patterns of the cholesterol–HDL-C–glucose index and risk of new-onset cardiometabolic multimorbidity: 9-year longitudinal evidence from CHARLS
Li, S., Tao, L., Wu, D., F, X., & Luo, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1835874
Progress in Mendelian Randomization Studies on the Causal Association of GLM7 Index Components with Stroke
王, 一. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1652171
Cardiometabolic risk status modifies the associations between remnant cholesterol with incident diabetes: evidence from two East Asian cohorts
Li, Y., Chen, Z.-Y., Shang, L., Wang, Y.-H., Liu, X.-Y., Yang, Y.-H., & He, L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1770876
Self-citation
Discordance between remnant cholesterol and LDL-C associated with the risk of new-onset cardiometabolic multimorbidity: A prospective cohort study
Rong, L., Fan, H.-D., Fang, Q., Li, X., Tan, J., & Huang, J. (2026) · Medicine · doi:10.1097/md.0000000000049157
Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model
Jiang, Y., Qian, A., Chen, S. H., Wu, Q., Xu, H., Zheng, C., Zhang, F., Xing, W., & He, J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1874711
An intervention study of the general practice management of older adults with cardiovascular metabolic comorbidities
Li, Y., Zou, Z., Yi, S., Yang, Y., Yuan, G., & Xu, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350895
Self-citation
Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts incident hypertension: a 9-year prospective cohort study in Chinese adults
Wu, X.-F., S, C., Zhang, Y.-C., Liu, S., Yan, B., & Li, X. G. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06008-z
Higher remnant cholesterol inflammatory index is associated with increased frailty risk in the UK Biobank
Zhou, Q., Liu, M., Wang, L., Wang, P., Qin, Y., Zhao, M., Wanyan, T., Yu, J., Wan, Y., Zhang, Q. X., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1864976
Remnant cholesterol and incident metabolic syndrome: evidence from a prospective cohort with emphasis on individuals with normal triglyceride levels
Tang, S., & Tao, Y. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104862

Authors: Zhao, Y., Zhuang, Z., Li, Y., Xiao, W., Song, Z., Huang, N., Wang, W., Dong, X., Jia, J., Clarke, R., & Huang, T.
Affiliations: Peking University (CN)
University of Oxford (GB)
Ministry of Education of the People's Republic of China (CN)
Corresponding author: Huang, Tao
ORCID: Zhao, Yimin
Zhuang, Zhenhuang
Li, Yueying
Xiao, Wendi
Song, Zimin
Huang, Ninghao
Wang, Wenxiu
Jia, Jinzhu
Clarke, Robert
Huang, Tao
Venue: Nature Communications
Publisher: Springer Science and Business Media LLC
Published: 2024-03-19
Volume: 15
Issue: 1
Pages: 2451-2451
ISSN: 2041-1723 (ISSN-L)
DOI: 10.1038/s41467-024-46686-x
PMC: PMC10951224
OpenAlex: W4392954776
Cited by: 117
References: 53
Citations by year: 2026: 52 · 2025: 47 · 2024: 17
FWCI: 38.20
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Nature Communications (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: National Natural Science Foundation of China (82173499, 82204026)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords: remnant cholesterol, triglycerides, cardiometabolic multimorbidity, type 2 diabetes, ischemic heart disease, stroke, triglyceride-rich lipoproteins, disease progression, multi-state models, Mendelian randomization, genetic instruments, causal inference
MeSH terms: Multimorbidity, Cholesterol, Diabetes Mellitus, Type 2, Humans, Hypercholesterolemia, Risk Factors, Triglycerides, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks